Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 156

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 156
---
ii) an increase of the company’s authorized
share capital; (iii) a merger; or (iv) an interested party transaction that requires shareholder approval.

In addition, a shareholder has a general duty to refrain from discriminating
against other shareholders. Certain shareholders also have a duty of fairness toward the company. These shareholders include any controlling
shareholder, any shareholder who knows that it has the power to determine the outcome of a shareholder vote and any shareholder who has
the power to appoint or to prevent the appointment of an office holder of the company or exercise any other rights available to it under
the company’s articles of association with respect to the company. The Companies Law does not define the substance of this duty
of fairness, except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach
of the duty of fairness. Israeli courts have not yet interpreted the scope or nature of any of these duties.

Approval of Private Placements

Under the Companies Law, a significant private placement of securities
requires approval by the board of directors and the shareholders by a simple majority. A private placement is considered a significant
private placement if it results in a person becoming a controlling shareholder, or if all of the following conditions are met: (i) the
securities issued amount to 20% or more of the company’s outstanding voting rights before the issuance; (ii) some or all of the
consideration is other than cash or listed securities or the transaction is not on market terms; and (iii) the transaction will increase
the relative holdings of a shareholder who holds 5% or more of the company’s outstanding share capital or voting rights, or will
cause any person to become, as a result of the issuance, a holder of more than 5% of the company’s outstanding share capital or
voting rights.

Exculpation, Insurance and Indemnification
of Office Holders

Under the Companies Law, a company may not exculpate an office
holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability
to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision
authorizing such exculpation is included in its articles of association. Our articles of association include such a provision. An Israeli
company may not exculpate a director from liability arising